According to the Zhitong Finance App, Guobang Pharmaceutical (605507.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 4.589 billion yuan, an increase of 2.66%; net profit to mother of 471 million yuan, a year-on-year decrease of 29.67%; deducted non-net profit of 447 million yuan, a year-on-year decrease of 27.88%; and basic earnings per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.